Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lille
Clinical trial register · France

Clinical Trials in Lille, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 2821 Lyon 1392 Bordeaux 1389 Marseille 1285 Lille 1282
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Lille138 Janssen Research & Development, LLC43 Hoffmann-La Roche40 AstraZeneca36 Assistance Publique - Hôpitaux de Paris34
Site location
Paris2821 Lyon1392 Bordeaux1389 Marseille1285 Lille1282
All 804 locations
Target enrolment
to

Trials with a site in Lille

1282 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
200
Angers, Bordeaux, Brest, Lille, Limoges, Lyon, Marseille, Montpellier
2021-03-06
Recruiting
Syndax Pharmaceuticals
Phase 2
296
La Tronche, Strasbourg, Toulouse, Amiens, Lille, Nancy, Nantes, Paris
2021-03-04
Recruiting
Study of Alcohol-related Liver Disease in Europe
NCT04400604Alcoholic Liver Disease
University Hospital, Lille
Observational
7,500
Lille
2021-03-03
Recruiting
Genethon
Phase 2/3
77
Bordeaux, Brest, Bron, Lille, Montpellier, Paris, Strasbourg
2021-03-01
Active, closed
Celgene
Phase 3
313
Angers, Clermont-Ferrand, Créteil, Grenoble, Lille, Lyon, Nice, Nîmes
2021-02-25
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
30
Lille
2021-02-25
Active, closed
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
Phase 3
455
Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Paris
2021-02-25
Active, closed
Bioverativ, a Sanofi company
Phase 3
261
Brest, Bron, Le Kremlin-Bicêtre, Lille, Marseille
2021-02-23
Active, closed
Hoffmann-La Roche
Phase 3
270
Bordeaux, Créteil, Lille, Montpellier, Pierre-Bénite, Rennes
2021-02-23
Active, closed
University Hospital, Montpellier
Phase 2
202
Amiens, Angers, Bondy, Clichy, Dijon, Grenoble, Lille, Marseille
2021-02-23
Recruiting
University Hospital, Lille
Observational
700
Lille
2021-02-18
Recruiting
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
NCT04545502Aneurysm, Dissection, Aortic Root Aneurysm, Aortic Root Dissection
Vascutek Ltd.
Observational
2,000
Bordeaux, Clermont-Ferrand, Dijon, Lille, Marseille, Rennes, Strasbourg, Toulouse
2021-02-17
Recruiting
Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
NCT04356326Chronic Hypertension Complicating Pregnancy, Pre-Eclampsia, Intrauterine Growth Restriction, Aspirin
DrugAspirin
Centre Hospitalier Intercommunal Creteil
Phase 3
500
Bordeaux, Caen, Clamart, Colombes, Créteil, Dijon, Le Kremlin-Bicêtre, Lille
2021-02-15
Recruiting
AB Science
Phase 3
495
Angers, Bordeaux, Bron, Clermont-Ferrand, Lille, Limoges, Marseille, Montpellier
2021-02-02
Recruiting
University Hospital, Lille
Phase 1
30
Lille
2021-01-31
Active, closed
AstraZeneca
Phase 3
1,371
Besançon, Bordeaux, Brest, Caen, Dijon, Le Mans, Lille, Montpellier
2021-01-28
Recruiting
Sanofi
Phase 1/2
258
Lille, Nantes, Paris
2021-01-25
Active, closed
Hoffmann-La Roche
Phase 2
920
Bordeaux, Lille, Lyon, Marseille, Toulouse, Villejuif
2021-01-18
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
126
Amiens, Bobigny, Bordeaux, Boulogne-Billancourt, Colombes, Créteil, Lille, Marseille
2021-01-07
Active, closed
Amgen
Phase 1/2
181
Le Chesnay, Lille, Nice, Paris, Pierre-Bénite, Toulouse
2021-01-04
Recruiting
Clinique de la Mitterie
Not applicable
112
Lille
2021-01-02
Recruiting
Real-Life Chronic Rhinosinusitis Outcome Registry
NCT04670172Chronic Rhinosinusitis (Diagnosis)
Change Accelerator in Respiratory Care
Observational
4,550
Lille
2021-01-01
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
548
Lyon, Pierre-Bénite, Dijon, Toulouse, Lille, Bordeaux, Poitiers, Nantes
2020-12-21
Active, closed
Stryker Neurovascular
Observational
405
Amiens, Besançon, Bordeaux, Brest, Clermont-Ferrand, Créteil, La Tronche, Lille
2020-12-21
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
182
Grenoble, Lille, Paris, Pessac
2020-12-18
Recruiting
Breastfeeding and Gut Health
NCT04195425Gut Health
University Hospital, Lille
Observational
500
Lille
2020-12-17
Active, closed
NETRIS Pharma
Phase 1/2
240
Besançon, Bordeaux, Caen, Dijon, Lille, Lyon, Marseille, Montpellier
2020-12-14
Recruiting
Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction
NCT04342546Breast Cancer, Capsular Contracture Associated With Breast Implant
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
250
Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Paris, Saint-Herblain
2020-12-11
Active, closed
AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT
NCT04225520Left Ventricular Dyssynchrony, Heart Failure, Cardiomyopathy, Dilated, Cardiac Remodeling, Ventricular
Universitaire Ziekenhuizen KU Leuven
Not applicable
500
Brest, Lille, Rennes
2020-12-10
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Bordeaux, Brest, Caen, Chambray-lès-Tours, Hyères, Lille, Limoges, Lyon
2020-12-07
Active, closed
Amgen
Phase 3
135
Clichy, Lille, Marseille, Nantes, Pessac
2020-12-04
Active, closed
Daiichi Sankyo
Phase 3
1,600
Bordeaux, Toulouse, Metz, Saint-Priest-en-Jarez, Dijon, La Roche-sur-Yon, La Tronche, Lille
2020-12-04
Recruiting
Ovarian Reserve and Bariatric Surgery
NCT04583150Bariatric Surgery, Obesity, Reproductive Health, Fertility
Assistance Publique - Hôpitaux de Paris
Observational
238
Angers, Clermont-Ferrand, Colombes, Dijon, Grenoble, Lille, Lyon, Marseille
2020-12-03
Active, closed
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy
NCT04463641Heart Failure, Cardiac Resynchronization Therapy
MicroPort CRM
Not applicable
92
Annecy, Chambray-lès-Tours, Clermont-Ferrand, Grenoble, Lille, Rennes, Rouen, Toulouse
2020-12-03
Active, closed
Hoffmann-La Roche
Phase 3
769
Besançon, Brest, Caen, Clermont-Ferrand, Lille, Nancy, Strasbourg
2020-12-03
Recruiting
Early Gestational Diabetes Mellitus
NCT04451915Gestational Diabetes
University Hospital, Lille
Not applicable
2,010
Arras, Clermont-Ferrand, Lille, Nîmes, Pessac, Pontoise, Saint-Pierre, Strasbourg
2020-11-30
Active, closed
Hoffmann-La Roche
Phase 3
864
Bordeaux, Clermont-Ferrand, Lille, Rouen
2020-11-26
Recruiting
Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer
NCT04528420Squamous Cell Carcinoma of Head and Neck
Centre Henri Becquerel
Not applicable
138
Amiens, Beauvais, Caen, Le Havre, Lille, Rouen, Saint-Quentin
2020-11-26
Active, closed
Eli Lilly and Company
Phase 3
312
Amiens, Bordeaux, Créteil, Lille, Marseille, Paris
2020-11-25
Active, closed
Institut Cancerologie de l'Ouest
Phase 1/2
44
Angers, Brest, Chambray-lès-Tours, Dijon, Le Mans, Lille, Lyon, Rennes
2020-11-17
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
300
Angers, Caen, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2020-11-11
Active, closed
Prevail Therapeutics
Phase 1/2
35
Saint-Pierre, Lille, Paris
2020-11-09
Recruiting
Meril Life Sciences Pvt. Ltd.
Not applicable
988
Créteil, Lille, Massy, Nice, Rennes
2020-11-04
Active, closed
Genmab
Phase 1/2
543
Lille, Marseille, Paris, Pierre-Bénite
2020-11-03
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Caen, Créteil, Dijon, Lille, Limoges, Marseille, Paris, Pessac
2020-11-03
Recruiting
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
NCT04688190Mitral Regurgitation, Mitral Valve Disease, Mitral Annular Calcification
Universitätsklinikum Hamburg-Eppendorf
Observational
1,000
Bourdeaux, Lille, Lyon, Toulouse
2020-11-01
Active, closed
Novartis Pharmaceuticals
Phase 2
134
Lille, Marseille, Paris, Pierre-Bénite, Toulouse, Villejuif
2020-10-30
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
DrugsXeloda·Sacituzumab Govitecan·Paraplatin·Capecitabine
GBG Forschungs GmbH
Phase 3
1,332
Angers, Avignon, Bordeaux, Bourg-en-Bresse, Caen, Clermont-Ferrand, Dijon, Lille
2020-10-28
Active, closed
AstraZeneca
Phase 3
640
Besançon, Lille, Lyon, Montpellier, Reims, Rouen, Strasbourg, Villejuif
2020-10-19
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Lille, Nice, Strasbourg
2020-10-15
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Bordeaux, Bron, Dijon, Le Mans, Lille, Nantes, Paris, Pessac
2020-10-13
Recruiting
Intact Cord Resuscitation in CDH
NCT04429750Rare Diseases, Congenital Diaphragmatic Hernia
University Hospital, Lille
Not applicable
180
Amiens, Lille, Nantes
2020-10-08
Active, closed
Hoffmann-La Roche
Phase 3
210
Pierre-Bnite, Lille
2020-10-08
Recruiting
University Hospital, Caen
Not applicable
35
Caen, Lille
2020-10-08
Recruiting
University Hospital, Lille
Not applicable
15
Lille
2020-10-08
Active, closed
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
NCT04093349Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2, Glycogen Storage Disease Type II
Spark Therapeutics, Inc.
Phase 1/2
4
Angers, Garches, Lille, Marseille, Nice
2020-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Bordeaux, Bron, La Tronche, Lille, Limoges, Marseille, Paris, Pessac
2020-09-30
Active, closed
Hoffmann-La Roche
Phase 3
190
Lille, Marseille
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Angers, Avignon, Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Lyon
2020-09-23
Recruiting
University Hospital, Toulouse
Phase 2
32
Grenoble, Lille, Marseille, Montpellier, Nantes, Poitiers, Toulouse
2020-09-22
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Lille, Lyon, Nantes, Poitiers, Toulouse, Tours
2020-09-17
Active, closed
AbbVie
Phase 3
531
Nice, Pessac, La Tronche, Lille, Nantes, Marseille, Rouen, Avignon
2020-09-10
Active, closed
Centre Oscar Lambret
Not applicable
25
Lille
2020-09-08
Active, closed
Hoffmann-La Roche
Phase 1/2
210
Toulouse, Dijon, Lille, Lyon, Marseille, Saint-Herblain, Villejuif
2020-09-03
Active, closed
Bristol-Myers Squibb
Observational
362
Lille
2020-09-02
Recruiting
Centre Georges Francois Leclerc
Phase 2
7,976
Amiens, Besançon, Bordeaux, Caen, Dijon, Levallois-Perret, Lille, Nantes
2020-08-25
Active, closed
Hoffmann-La Roche
Phase 3
271
Créteil, Lille, Paris, Toulouse
2020-08-10
Recruiting
Eisai Inc.
Phase 1/2
182
Nice, Strasbourg, Marseille, Caen, Saint-Brieuc, Nantes, Lille, Bayonne
2020-08-06
Active, closed
AstraZeneca
Phase 3
185
Lille, Lyon, Plérin, Villejuif
2020-08-04
Recruiting
University Hospital, Lille
Not applicable
120
Lille
2020-07-21
Active, closed
AstraZeneca
Phase 3
134
Lille, Pessac, Strasbourg, Suresnes, Toulouse
2020-07-20
Recruiting
Deployment o the Multidisciplinary Prospective Cohort Imminent
NCT04334031Chronic Inflammatory Disease, Angioedema, Severe Asthma, Lupus
University Hospital, Lille
Not applicable
2,200
Lille
2020-07-20
Recruiting
Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
NCT04330118Drug Hypersensitivity, DRESS Syndrome
University Hospital, Lille
Observational
80
Arras, Boulogne-sur-Mer, Créteil, Douai, Dunkirk, Lens, Lille, Roubaix
2020-07-15
Recruiting
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
NCT03651206Ovarian Carcinosarcoma, Endometrial Carcinosarcoma
DrugNiraparib
ARCAGY/ GINECO GROUP
Phase 2/3
138
Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Lille
2020-07-15
Active, closed
Celgene
Phase 2
276
Lille, Montpellier, Paris, Pierre-Bénite, Rennes, Toulouse
2020-07-14
Active, closed
GlaxoSmithKline
Phase 3
242
Lille
2020-07-14
Recruiting
Jules Bordet Institute
Not applicable
600
Lille, Marseille, Paris, Rouen, Strasbourg, Toulouse
2020-07-01
Active, closed
Actelion
Phase 3
935
Brest, Caen, Le Kremlin-Bicêtre, Lille, Marseille, Nice, Saint-Priest-en-Jarez, Toulouse
2020-06-30
Active, closed
Sanofi
Phase 3
337
Ars-Laquenexy, Bayonne, Grenoble, La Roche-sur-Yon, Lille, Paris, Poitiers, Rennes
2020-06-16
Recruiting
Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
NCT04434586Superficial Femoral Artery Stenosis, Claudication, Ischemic Leg
University Hospital, Lille
Not applicable
166
Lille
2020-06-16
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Lille, Lyon, Montpellier, Nantes, Paris, Poitiers, Toulouse
2020-06-12
Active, closed
GlaxoSmithKline
Phase 1/2
106
Lille, Villejuif
2020-06-08
Recruiting
Centre Antoine Lacassagne
Phase 2
103
Bordeaux, Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice
2020-06-04
Active, closed
Nantes University Hospital
Phase 3
42
Angers, Clermont-Ferrand, Clichy, Créteil, Lille, Lyon, Nancy, Nantes
2020-03-12
Recruiting
Centre Leon Berard
Not applicable
168
Besançon, Bordeaux, Lille, Lyon, Marseille, Montpellier, Paris, Poitiers
2020-03-03
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
20
Lyon, Lille, Montpellier, Toulouse, Marseille, Nice, Paris
2020-02-25
Active, closed
University Hospital, Lille
Observational
2,000
Lille
2020-02-17
Recruiting
Hospices Civils de Lyon
Phase 1/2
26
Pierre-Bénite, Bordeaux, Caen, Lille, Marseille, Nice, Paris, Rennes
2020-02-12
Active, closed
Centre Georges Francois Leclerc
Phase 2
270
Amiens, Besançon, Bordeaux, Dijon, Levallois-Perret, Lille, Lyon
2020-02-10
Recruiting
Brain-injured Patients Extubation Readiness Study
NCT04080440Mechanical Ventilator Weaning, Acute Brain Injury, Altered Level of Consciousness, Mechanical Ventilation
University Hospital, Clermont-Ferrand
Not applicable
660
Angers, Bordeaux, Bourg-en-Bresse, Caen, Clermont-Ferrand, Grenoble, La Réunion, Lille
2020-02-09
Recruiting
Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study
NCT04194619Vascular Anomaly, Osler Rendu Disease, Marfan Syndrome or Related, Lymphedema Primary
Hospices Civils de Lyon
Observational
400
Angers, Bordeaux, Boulogne-Billancourt, Bron, Caen, Clermont-Ferrand, Dijon, Lille
2020-02-06
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Clermont-Ferrand, Dijon, Lille, Lyon, Toulouse
2020-01-29
Active, closed
Actelion
Phase 3
138
Lille, Marseille, Montpellier, Paris, Pessac, Toulouse
2020-01-16
Recruiting
Poitiers University Hospital
Observational
6,000
Angoulême, Argenteuil, Béthune, Chartres, Lille, Montpellier, Nantes, Poitiers
2020-01-09
Active, closed
UNICANCER
Phase 3
490
Albi, Angers, Bordeau, Dijon, Le Puy-en-Velay, Lille, Montpellier, Nice
2020-01-09
Active, closed
Institut de Recherches Internationales Servier
Phase 3
331
Lille, Lyon, Marseille, Paris
2020-01-05
Active, closed
The Netherlands Cancer Institute
Phase 3
538
Besançon, Bordeaux, Lille, Lyon, Montpellier, Nantes, Paris, Strasbourg
2020-01-01
Recruiting
University Hospital, Lille
Observational
100
Lille
2020-01-01
Recruiting
University Hospital, Lille
Observational
10,000
Boulogne-sur-Mer, Lille
2019-12-20
Recruiting
Natural History of Duchenne Muscular Dystrophy
NCT03882827Duchenne Muscular Dystrophy
Genethon
Observational
220
Bordeaux, Brest, Bron, Lille, Marseille, Montpellier, Paris, Strasbourg
2019-12-19
Recruiting
Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NCT03728049Aortic Valve Stenosis, Aortic Valve Insufficiency
University Hospital, Lille
Not applicable
944
Clermont-Ferrand, Lille, Montpellier, Nîmes, Paris, Pessac, Rennes, Strasbourg
2019-12-18
Active, closed
C. R. Bard
Not applicable
477
Lille, Dijon, Paris, Pierre-Bénite, Reims, Strasbourg
2019-12-12
Recruiting
Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study
NCT04170634Metastases to Bone, Metastatic Breast Cancer, Metastatic NSCLC
Hospices Civils de Lyon
Observational
220
Angers, Annecy, Clermont-Ferrand, Contamine-sur-Arve, Lille, Lyon, Paris, Pierre-Bénite
2019-11-28
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Pessac, Caen, Pierre-Bénite, Lille, Nantes, Poitiers, Paris, Créteil
2019-11-13
Recruiting
University Hospital, Lille
Not applicable
34
Lille
2019-11-12
Active, closed
Janssen Research & Development, LLC
Phase 2
208
Lille, Nantes, Paris
2019-11-07
Active, closed
Novartis Pharmaceuticals
Phase 1
120
Lille, Lyon, Marseille, Villejuif
2019-10-30
Active, closed
Bristol-Myers Squibb
Phase 3
790
Brest, Besançon, Bordeaux, Lille, Marseille, Nantes, Nice, Paris
2019-10-28
Recruiting
GlaxoSmithKline
Phase 1/2
184
Bordeaux, Lille, Marseille, Montpellier, Nantes, Paris, Toulouse
2019-10-25
Recruiting
University Hospital, Lille
Observational
447
Angers, Besançon, Bondy, Caen, La Tronche, Lille, Marseille, Montpellier
2019-10-23
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
32
Besançon, Créteil, Levallois-Perret, Lille, Lyon, Montpellier, Nantes, Paris
2019-10-23
Active, closed
Biogen
Phase 3
152
Strasbourg, Toulouse, Montpellier, Lille, Le Kremlin-Bicêtre
2019-10-18
Active, closed
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
NCT04050436Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
DrugsVusolimogene Oderparepvec·Cemiplimab
Replimune, Inc.
Phase 2
231
Besançon, Dijon, La Tronche, Lille, Lyon, Marseille, Nice, Paris
2019-10-08
Active, closed
GlaxoSmithKline
Phase 1/2
208
Lille, Villejuif
2019-10-07
Active, closed
Celgene
Phase 1/2
424
Lille, Marseille, Nantes, Toulouse, Tours
2019-09-30
Active, closed
RECORDATI GROUP
Observational
125
Lille, Marseille, Villejuif
2019-09-30
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Caen, Clichy, Lille, Montpellier, Nice, Paris, Pessac, Pierre-Bénite
2019-09-26
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
DrugsTulmimetostat·Enzalutamide
Novartis Pharmaceuticals
Phase 1/2
300
Bordeaux, Lille, Lyon, Nantes, Saint-Herblain, Strasbourg, Villejuif
2019-09-18
Active, closed
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
DrugXeomin
Merz Pharmaceuticals GmbH
Phase 3
603
Garches, Lille, Rennes, Strasbourg, Toulouse
2019-09-16
Active, closed
Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study
NCT04038138Muscular Dystrophy, Facioscapulohumeral
Centre Hospitalier Universitaire de Nice
Not applicable
100
Lille, Nice, Paris
2019-09-16
Active, closed
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
NCT04067336Advanced Malignant Neoplasm, Acute Myeloid Leukemia, Mixed Lineage Leukemia, Mixed Lineage Acute Leukemia
DrugsZiftomenib·Itraconazole·Midazolam
Kura Oncology, Inc.
Phase 1/2
263
Lille, Nantes, Paris, Pessac, Pierre-Bénite, Villejuif
2019-09-12
Recruiting
LAparoscopic Preventive PRErectal Mesh
NCT03766048Urogenital Prolapse
University Hospital, Lille
Not applicable
834
Clermont-Ferrand, Dunkirk, La Rochelle, Le Mans, Lille, Nice, Nîmes, Poissy
2019-09-11
Active, closed
Nyxoah S.A.
Not applicable
110
Angers, Créteil, Lille, Montpellier, Paris, Rennes, Toulouse
2019-09-01
Recruiting
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
NCT04832607AdV Infection, EBV Infection, CMV Infection, Stem Cell Transplant Complications
Tobias Feuchtinger
Phase 3
149
Lille, Lyon, Nancy, Paris
2019-08-27
Recruiting
University Hospital, Lille
Not applicable
24
Lille
2019-08-27
Active, closed
BeOne Medicines
Phase 3
510
Bordeaux, Brest, Dijon, Grenoble, Le Mans, Lille, Marseille, Nantes
2019-08-20
Active, closed
Sanofi
Observational
1,860
Argenteuil, Bordeaux, Lille, Marseille, Martigues, Nantes, Paris, Toulouse
2019-08-15
Active, closed
Hoffmann-La Roche
Phase 1/2
498
Lille, Montpellier, Pierre-Bénite, Rennes
2019-08-13
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Angers, Créteil, La Tronche, Lille, Marseille, Paris, Pessac, Pierre-Bénite
2019-08-12
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Bordeaux, Vandœuvre-lès-Nancy, Clermont-Ferrand, Créteil, Dijon, La Tronche, Lille, Marseille
2019-08-09
Active, closed
Bristol-Myers Squibb
Phase 3
839
Limoges, Lille, Bayonne, Besançon, Lyon, Marseille, Montpellier, Nantes
2019-08-05
Active, closed
Nantes University Hospital
Phase 2
50
Nantes, Caen, Dijon, Grenoble, La Roche-sur-Yon, Lille, Lyon, Pessac
2019-07-30
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
197
Lille, Lyon, Villejuif
2019-07-17
Recruiting
University Hospital, Lille
Not applicable
396
Amiens, Boulogne-sur-Mer, Lille, Valenciennes
2019-06-16
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
366
Bordeaux, Brou, Caen, Clermont-Ferrand, La Roche-sur-Yon, Lille, Limoges, Lyon
2019-06-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Dijon, Bordeaux, Boulogne-Billancourt, La Tronche, Lille, Lyon, Nantes, Nice
2019-06-04
Recruiting
HighLife SAS
Not applicable
120
Toulouse, Lille, Lyon, Massy, Nantes, Paris, Pessac, Rennes
2019-05-28
Active, closed
Celgene
Phase 1/2
438
Bordeaux, Créteil, Lille, Montpellier, Paris, Pierre-Bénite, Rouen, Toulouse
2019-05-20
Recruiting
Natural History of Hypereosinophilia and Hypereosinophilic Syndromes
NCT04018118Eosinophilia, Hypereosinophilic Syndrome
DrugBiological sample
University Hospital, Lille
Observational
600
Lille
2019-05-06
Active, closed
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)
NCT03842982Ovary Neoplasms, Ovarian Cancer, Ovarian Carcinoma
DrugHipec
Centre Oscar Lambret
Phase 3
362
Angers, Bordeaux, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier, Paris
2019-05-03
Recruiting
GENetic Fronto Temporal Dementia Initiative in Lille
NCT04639622Frontotemporal Dementia
University Hospital, Lille
Not applicable
20
Lille
2019-04-23
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Strasbourg, Lyon, Clermont-Ferrand, Rennes, Besançon, Lille, Montpellier, Limoges
2019-03-28
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Besançon, Lille, Nantes, Nice, Paris, Pessac, Poitiers, Strasbourg
2019-03-22
Active, closed
Institut Cancerologie de l'Ouest
Phase 2
96
Bordeaux, Brest, Dijon, Lille, Lorient, Lyon, Montpellier, Pierre-Bénite
2019-03-21
Active, closed
Centre Oscar Lambret
Not applicable
280
Lille, Dechy, Montpellier, Sarcelles, Strasbourg, Vandœuvre-lès-Nancy, Villejuif
2019-03-13
Recruiting
University Hospital, Lille
Observational
500
Lille
2019-03-13
Active, closed
Durvalumab and Tremelimumab for Pediatric Malignancies
NCT03837899Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies
DrugDurvalumab
AstraZeneca
Phase 1/2
50
Lille, Marseille, Paris
2019-03-07
Active, closed
Hoffmann-La Roche
Phase 3
1,000
Angers, Nice, Lille, Marseille, Villejuif
2019-02-28
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Bordeaux, Dijon, Lille, Lyon, Marseille, Paris, Poitiers, Saint-Herblain
2019-02-08
Recruiting
Centre Leon Berard
Phase 2
40
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lille, Limoges, Lyon, Marseille
2019-01-23
Recruiting
Polysomnographic Findings in Nasal Polyposis
NCT03725956Chronic Rhinosinusitis With Nasal Polyps, Obstructive Sleep Apnea
University Hospital, Lille
Not applicable
30
Lille
2019-01-17
Recruiting
Avoiding Anticoagulation After IntraCerebral Haemorrhage
NCT03243175Intracerebral Hemorrhage, Atrial Fibrillation, Microhaemorrhage
DrugApixaban
University Hospital, Lille
Phase 3
300
Lille, Lomme, Tourcoing
2019-01-17
Active, closed
UNICANCER
Phase 3
517
Angers, Bordeaux, Clermont-Ferrand, Ermont, Grenoble, Hyères, Le Kremlin-Bicêtre, Lille
2019-01-17
Active, closed
9-ING-41 in Patients With Advanced Cancers
NCT03678883Cancer, Pancreatic Cancer, Sarcoma, Renal Cancer
DrugsCCNU·Lomustine·Abraxane·Adriamycin
Actuate Therapeutics Inc.
Phase 2
350
Besançon, Brest, Lille, Vandœuvre-lès-Nancy, Bordeaux, Saint-Herblain, Marseille
2019-01-04
Active, closed
Celgene
Phase 3
363
Angers, Bayonne, Caen, La Tronche, Le Mans, Lille, Limoges, Nantes
2019-01-02
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
45
Paris, Villejuif, Bordeaux, Créteil, Lille, Lyon, Toulouse, Vandœuvre-lès-Nancy
2019-01-02
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Lille, Montpellier, Nantes, Nice, Nîmes, Paris, Strasbourg
2018-12-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Caen, Dijon, Toulouse, Lille, Saint-Cloud, Montpellier, Metz, Avignon
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Dijon, Rennes, Suresnes, Lille, Créteil
2018-12-24
Active, closed
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
NCT03614260Hypertension, Vascular Diseases, Cardiovascular Diseases
ReCor Medical, Inc.
Not applicable
224
Bordeaux, Lille, Paris
2018-12-14
Active, closed
UNICANCER
Phase 2
79
Bordeaux, Clermont-Ferrand, Dijon, Lille, Montpellier, Mougins, Nice, Paris
2018-12-14
Active, closed
Institut Cancerologie de l'Ouest
Not applicable
256
Avignon, Bordeaux, Brest, Chalon-sur-Saône, Clermont-Ferrand, Dijon, Lille, Lyon
2018-12-04
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
271
Amiens, Besançon, Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Lille, Lyon
2018-10-30
Active, closed
UNICANCER
Phase 2
60
Amiens, Angers, Bordeaux, Caen, La Tronche, Lille, Lyon, Marseille
2018-10-23
Active, closed
AbbVie
Phase 3
265
La Tronche, Reims, Vandœuvre-lès-Nancy, Lille, Créteil, Nantes, Pierre-Bénite, Rouen
2018-10-22
Active, closed
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
NCT03438552Local Recurrence of Malignant Tumor of Prostate
UNICANCER
Not applicable
57
Caen, Clermont-Ferrand, Dijon, Lille, Lyon, Montpellier, Paris, Rennes
2018-10-18
Recruiting
Medical Economic Evaluation of Bilateral Allograft of Hands and Forearms
NCT02797457Bilateral Traumatic Amputation of Upper Limbs
Hospices Civils de Lyon
Not applicable
40
Berck, Bruges, Clamart, Lille, Lyon, Miribel, Nancy, Ploemeur
2018-10-16
Active, closed
AbbVie
Phase 2
270
Marseille, Bordeaux, Lille, Paris, Bron, Lyon, Créteil, Villejuif
2018-10-10
Active, closed
Hospices Civils de Lyon
Phase 3
108
Aix-en-Provence, Besançon, Bordeaux, Colmar, Lille, Lyon, Marseille, Paris
2018-10-02
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
315
Villejuif, Lille, Paris, Rennes
2018-08-29
Active, closed
Gilead Sciences
Phase 2
502
Besançon, Bordeaux, Brest, Clermont-Ferrand, La Roche-sur-Yon, Lille, Lyon, Marseille
2018-08-13
Active, closed
Centre Leon Berard
Phase 2
62
Bordeaux, Lille, Lyon, Toulouse, Villejuif
2018-08-01
Recruiting
Determinants of the Long-Term Success of Bariatric Surgery
NCT03517072Morbid Obesity, Bariatric Surgery Candidate
University Hospital, Lille
Observational
1,000
Arras, Boulogne-sur-Mer, Lille, Valenciennes
2018-07-31
Recruiting
Celgene
Phase 2/3
1,541
Creteil-Paris, Lille, Lyon, Marseille, Montpellier, Nantes, Paris, Pessac
2018-07-19
Active, closed
Eli Lilly and Company
Phase 3
1,058
Amiens, Chambray-lès-Tours, Lille, Montpellier, Neuilly-sur-Seine, Nice, Paris, Pau
2018-07-18
Active, closed
OFSEP High Definition Cohort
NCT03603457Multiple Sclerosis
EDMUS Foundation
Observational
2,842
Besançon, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Grenoble, Lille
2018-07-10
Recruiting
University Hospital, Lille
Phase 2
28
Lille, Paris
2018-06-25
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Observational
150
Villejuif, Créteil, Lille, Lyon, Marseille, Montpellier, Nantes, Nice
2018-06-22
Recruiting
University Hospital, Lille
Not applicable
100
Lille
2018-06-20
Active, closed
Exelixis
Phase 3
837
Amiens, Besançon, Bondy, Caen, Clichy, Grenoble, Lille, Lyon
2018-06-10
Active, closed
Hoffmann-La Roche
Phase 3
927
Bayonne, Bordeaux, Bron, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier
2018-05-28
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Le Mans, Lille, Marseille, Paris, Pessac, Pierre-Bénite, Toulouse
2018-05-03
Active, closed
UNICANCER
Not applicable
81
Angers, Bordeaux, Caen, Dijon, Grenoble, Lille, Limoges, Lorient
2018-04-19
Active, closed
Bristol-Myers Squibb
Phase 3
545
Bobigny, Brest, Clermont-Ferrand, Clichy, Créteil, Grenoble, Lille, Lyon
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Clermont-Ferrand, Lille, Montpellier, Pessac, Reims, Toulouse, Tours, Vandœuvre-lès-Nancy
2018-04-17
Active, closed
Hospices Civils de Lyon
Observational
670
Amiens, Angers, Bordeaux, Clichy, Dijon, Lille, Lyon, Marseille
2018-04-16
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Amiens, Bayonne, Besançon, Caen, Chambray Les Tours Centre, Créteil, Grenoble, Lille
2018-04-13
Active, closed
Centre Oscar Lambret
Not applicable
132
Lille
2018-04-12
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Rennes, Amiens, Bordeaux, Lille, Marseille, Paris, Pierre-Bénite, Poitiers
2018-04-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Lyon, Marseille, Bordeaux, Lille, Villejuif, Paris
2018-04-09
Active, closed
AbbVie
Phase 3
1,336
Nice, Montpellier, La Tronche, Vandœuvre-lès-Nancy, Pessac, Lille, St-Priest-en-Jarez, Pierre-Bénite
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Angers, Besançon, Bordeaux, Brest, Clermont-Ferrand, Dijon, Lille, Lorient
2018-03-23
Active, closed
AbbVie
Phase 3
747
Nice, Pessac, Toulouse, Montpellier, La Tronche, Vandœuvre-lès-Nancy, Lille, Valenciennes
2018-03-21
Active, closed
AstraZeneca
Phase 2
273
Angers, Besançon, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier
2018-03-07
Active, closed
Nantes University Hospital
Not applicable
330
Angers, Annecy, Bordeaux, Brest, Créteil, Grenoble, Le Plessis-Robinson, Lille
2018-03-02
Recruiting
Post-Operative Myocardial Incident & Atrial Fibrillation
NCT03376165Valve Heart Disease, Coronary Artery Disease
University Hospital, Lille
Observational
1,500
Lille
2018-01-30
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
NCT03142152Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases
Cardiac Dimensions, Inc.
Not applicable
300
Clermont-Ferrand, Lille, Lyon, Montpellier, Paris
2018-01-01
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Pessac, Lille, Paris
2017-12-29
Recruiting
Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
NCT02838602Malignant Tumors as Chordoma, Adenoid Cystic Carcinoma and Sarcoma
Hospices Civils de Lyon
Not applicable
250
Amiens, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille, Lyon, Marseille
2017-12-23
Recruiting
MPS (RaDiCo Cohort) (RaDiCo-MPS)
NCT06036693Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis III, Mucopolysaccharidosis IV
Institut National de la Santé Et de la Recherche Médicale, France
Observational
1,000
Angers, Bordeaux, Brest, Clermont-Ferrand, Clichy, Garches, Lille, Marseille
2017-12-20
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Lille, Paris
2017-12-16
Active, closed
Sanofi
Phase 3
475
Bayonne, Caen, Dijon, La Roche-sur-Yon, Lille, Nantes, Paris, Pessac
2017-12-07
Active, closed
MOther-Child Interaction Assessment TRAINING for Pediatricians
NCT03300713Child Behavior Disorders, Mother-child Relations, Depression, Postpartum
University Hospital, Lille
Not applicable
3,504
Lille
2017-12-02
Active, closed
AstraZeneca
Phase 3
1,324
Clichy, Lille, Marseille, Montpellier, Nancy, Nantes, Nice, Pessac
2017-10-11
Recruiting
UNICANCER
Observational
75,000
Angers, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Lille, Lyon
2017-10-02
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Bordeaux, Caen, Lille, Lyon, Nîmes, Nouilly, Paris, Poitiers
2017-09-22
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Bordeaux, Bron, Lille, Montpellier, Nantes, Paris, Toulouse
2017-09-12
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
La Roche-sur-Yon, Villejuif, Bordeaux, Brest, Caen, Le Mans, Lille, Lyon
2017-09-05
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Amiens, Bron, Lille, Marseille, Strasbourg
2017-08-23
Recruiting
Coloplast A/S
Observational
130
Angers, Besançon, Caen, Chalon-sur-Saône, Créteil, Lille, Lorient, Lyon
2017-06-29
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Angers, Avignon, Bordeaux, Caen, Cholet, Clermont-Ferrand, Dijon, Lille
2017-06-21
Recruiting
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
NCT04220970Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
The Lymphoma Academic Research Organisation
Observational
150
Avignon, Bordeaux, Brest, Colmar, Créteil, Dijon, Lille, Lyon
2017-06-07
Recruiting
DCP (RaDiCo Cohort) (RaDiCo-DCP)
NCT05951478Primary Ciliary Dyskinesia
Institut National de la Santé Et de la Recherche Médicale, France
Observational
300
Besançon, Bordeaux, Caen, Créteil, Dijon, Le Kremlin-Bicêtre, Lille, Lyon
2017-05-01
Active, closed
Bristol-Myers Squibb
Phase 3
1,314
Nîmes, Lille, Marseille, Saint-Priest-en-Jarez, Suresnes, Tours, Villejuif
2017-03-24
Recruiting
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
NCT05945576Silver Russell Syndrome, Beckwith-Wiedemann Syndrome, Transient Neonatal Diabetes Mellitus, Angelman Syndrome
Institut National de la Santé Et de la Recherche Médicale, France
Observational
2,000
Angers, Besançon, Clermont-Ferrand, Le Kremlin-Bicêtre, Lille, Limoges, Lyon, Marseille
2017-03-10
Recruiting
University Hospital, Lille
Observational
542
Lille
2017-03-09
Active, closed
Hoffmann-La Roche
Phase 1/2
940
Créteil, Lille, Montpellier, Pierre-Bénite, Rennes
2017-02-21
Active, closed
AbbVie
Phase 3
950
Nice, Montpellier, Lille, Pierre-Bénite, La Roche-sur-Yon, Saint-Etienne
2017-01-31
Recruiting
Institut Curie
Not applicable
1,050
Bordeaux, Lille, Lyon, Paris, Saint-Cloud, Vandœuvre-lès-Nancy
2017-01-06
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Bordeaux, La Roche-sur-Yon, Lille, Lyon, Montpellier, Nîmes, Paris, Saint-Herblain
2016-12-22
Active, closed
SEDVasc (RaDiCo Cohort) (RaDiCo-SEDVasc)
NCT05976841Ehlers-Danlos Syndrome, Vascular Type
Institut National de la Santé Et de la Recherche Médicale, France
Observational
340
Angers, Bordeaux, Brest, Caen, Clermont-Ferrand, Grenoble, Lille, Lyon
2016-12-05
Active, closed
Centre Oscar Lambret
Not applicable
140
Bondy, Bordeaux, Caen, Clamart, Dijon, La Réunion, Lille, Limoges
2016-12
Active, closed
Eli Lilly and Company
Phase 1
223
Paris, Lille, Villejuif
2016-11-21
Recruiting
University Hospital, Lille
Not applicable
120
Clermont-Ferrand, Lille, Paris, Poissy, Rouen
2016-11-17
Active, closed
Eli Lilly and Company
Phase 1
100
Lille, Montpellier, Toulouse
2016-11-14
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
NCT02325674Generalised Lipodystrophy, Partial Lipodystrophy
DrugMetreleptin
Chiesi Farmaceutici S.p.A.
Observational
100
Lille, Paris
2016-10-11
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Pessac, Toulouse, Saint-Herblain, Saint-Nazaire, Angers, Cholet, Lorient, Lille
2016-09-13
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2
472
Villejuif, Angers, Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2016-08-03
Active, closed
Celgene
Phase 1/2
130
Lille, Marseille, Paris, Pessac, Pierre-Bénite, Toulouse, Villejuif
2016-06-03
Recruiting
Institut Bergonié
Not applicable
205
Bordeaux, Dijon, Lille, Lyon, Marseille, Nantes, Paris, Toulouse
2016-06
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Lille, Montpellier, Rennes, Vellefaux
2016-06
Active, closed
Eli Lilly and Company
Phase 2
309
Lyon, Bordeaux, Besançon, Lille, Montpellier, Nice, Villejuif
2016-05-19
Active, closed
NeuroDerm Ltd.
Phase 2
214
Aix-en-Provence, Amiens, Bron, Clermont-Ferrand, Lille, Marseille, Poitiers
2016-05-04
Active, closed
Centre Oscar Lambret
Not applicable
628
Angers, Besançon, Bordeaux, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille
2016-03-22
Active, closed
Tesaro, Inc.
Phase 1
729
Bordeaux, Caen, Clermont-Ferrand, Lille, Marseille, Paris, Saint-Herblain, Villejuif
2016-03-07
Active, closed
Medtronic Cardiovascular
Not applicable
2,223
Lille, Massy, Toulouse
2016-03
Active, closed
ReCor Medical, Inc.
Not applicable
282
Bordeaux, Lille, Lyon, Paris, Toulouse
2016-03
Active, closed
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
NCT02710435Angina Pectoris, Angina Pectoris, Stable, Chronic Stable Angina
Shockwave Medical, Inc.
Observational
400
Brest, Lille
2016-03
Recruiting
University Hospital, Lille
Observational
85
Amiens, Bron, Lille, Marseille, Montpellier, Paris, Strasbourg
2016-02-03
Active, closed
AbbVie
Phase 3
1,629
Toulouse, Lille, Montpellier, Bordeaux, Caen, Clermont-Ferrand, Marseille, Paris
2015-12-01
Active, closed
AstraZeneca
Phase 3
682
Bron, Lille, Limoges, Lyon, Paris
2015-10-21
Active, closed
AstraZeneca
Phase 3
1,118
Bordeaux, Brest, Créteil, Lille, Lyon, Marseille
2015-07-21
Active, closed
Medtronic
Observational
3,100
Annecy, Bayonne, Bordeaux, Brest, Chambray-lès-Tours, Clermont-Ferrand, Grenoble, Lille
2015-07
Active, closed
Eli Lilly and Company
Phase 3
545
Montpellier, La Tronche, Lille, Poitiers, Paris
2015-05-06
Active, closed
Medtronic Cardiovascular
Not applicable
128
Lille, Toulouse
2015-04
Active, closed
Acerta Pharma BV
Phase 2
124
Angers, Caen, Clermond Ferrand, Créteil, Dijon, Grenoble, La Roche - Sure-Yon, Lille
2015-03-02
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Toulouse, Lille, Paris, Poitiers, Lyon, Le Kremlin-Bicêtre
2015-01-20
Recruiting
Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease
NCT03773887Liver Diseases, Acute on Chronic Hepatic Failure
University Hospital, Lille
Not applicable
450
Lille
2014-12-25
Active, closed
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
NCT02243605Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma, Recurrent Osteosarcoma
DrugsCabozantinib S-malate·Cabozantinib
National Cancer Institute (NCI)
Phase 2
90
Bordeaux, Dijon, Lille, Lyon, Marseille, Nice, Paris, Saint-Herblain
2014-12-19
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Angers, Brest, La Roche-sur-Yon, Lille, Montpellier, Nantes, Paris, Saint-Grégoire
2014-12-17
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
Bordeaux, Lille, Lyon, Paris
2014-12-04
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Pierre-Bénite, Créteil, Dijon, La Rochelle, Lille, Marseille, Montpellier, Paris
2014-11
Active, closed
Eli Lilly and Company
Phase 3
453
Bron, Dijon, Grenoble, Lille, Marseille, Poitiers, Rennes, Saint-Brieuc
2014-10-03
Recruiting
Centre Hospitalier Universitaire, Amiens
Phase 2
50
Amiens, Bordeaux, Dijon, Lille, Lyon, Marseille, Montpellier, Nancy
2014-09-12
Recruiting
UNICANCER
Observational
42,000
Angers, Bordeaux, Caen, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille
2014-07
Recruiting
Imagine Institute
Observational
1,445
Bordeaux, Bron, Lille, Marseille, Paris, Rennes, Strasbourg, Toulouse
2014-06-16
Active, closed
University Hospital, Toulouse
Observational
1,700
Bordeaux, Clichy, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2014-05
Active, closed
UNICANCER
Phase 2
1,460
Angers, Avignon, Bordeaux, Caen, Clermont-Ferrand, Dijon, La Roche-sur-Yon, Lille
2014-04-07
Recruiting
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
NCT01356290Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent, Rare CNS Tumor Recurrent
DrugsThalidomide·Celecoxib·Temozolomide·Cytarabine
Medical University of Vienna
Phase 2
232
Lille, Lyon
2014-04
Recruiting
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
NCT02595255Fertility Preservation, Lymphoma, Pediatrics Cancer, Gonadotropin-releasing Hormone Agonist
Erasme University Hospital
Observational
275
Lille
2014-04
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
154
Villejuif, Avignon, Caen, Dijon, Lille, Marseille, Montpellier, Nice
2014-02-26
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
112
Créteil, Dijon, Estaing, Grenoble, Lille, Lyon, Marseille, Montpellier
2013-12
Active, closed
AstraZeneca
Phase 3
510
Brest, Caen, Clermont-Ferrand, Dijon, Lille, Marseille, Paris, Pierre-Bénite
2013-09-25
Active, closed
MedImmune LLC
Phase 2
571
Caen, Le Mans, Lille, Nice, Rennes, Toulouse, Villejuif
2013-05-17
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bordeaux, Clermont-Ferrand, Grenoble, Lille, Lyon, Marseille, Montpellier, Nancy
2013-04
Active, closed
Centre Hospitalier Universitaire de Nice
Observational
246
Colmar, Clermont-Ferrand, Épagny, Grenoble, Lille, Limoges, Lyon, Marseille
2013-03
Active, closed
University Hospital, Lille
Phase 1/2
35
Amiens, Lille, Marseille, Rouen
2013-03
Active, closed
Washington University School of Medicine
Phase 2/3
490
Toulouse, Lille, Paris, Bron, Rouen
2012-12
Recruiting
University Hospital, Lille
Not applicable
314
Lille
2012-10
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Strasbourg, Amiens, Angers, Bordeaux, Clermont-Ferrand, Créteil, Lille, Marseille
2012-07
Active, closed
University Hospital, Lille
Observational
59
Caen, Lille, Rouen
2012-05-21
Active, closed
Radical Fimbriectomy for Young BRCA Mutation Carriers
NCT01608074BRCA1 Mutation, BRCA2 Mutation, Hereditary Breast and Ovarian Cancer
Centre Oscar Lambret
Not applicable
123
Aix-en-Provence, Bordeaux, Clermont-Ferrand, Lille, Lyon, Marseille, Nice, Paris
2012-01-09
Active, closed
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
NCT01385176Heart Failure, Congestive Heart Failure
Boston Scientific Corporation
Not applicable
118
Vandœuvre-lès-Nancy, Lille
2011-09-21
Active, closed
UNICANCER
Phase 3
700
Amiens, Besançon, Bordeaux, Brest, Créteil, Dijon, La Roche-sur-Yon, Lille
2011-07
Active, closed
Vismodegib in Treating Patients With Advanced Chondrosarcomas
NCT01267955Clear Cell Chondrosarcoma, Dedifferentiated Chondrosarcoma, Locally Advanced Chondrosarcoma, Mesenchymal Chondrosarcoma
DrugVismodegib
National Cancer Institute (NCI)
Phase 2
45
Bordeaux, Lille, Lyon, Marseille, Paris, Villejuif
2010-12-21
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
40
Nice, Lille, Marseille, Nantes, Nîmes, Paris, Poitiers, Rennes
2010-01-01
Recruiting
Saint-Louis Hospital, Paris, France
Not applicable
575
Amiens, Bordeaux, Clermont-Ferrand, Clichy, Créteil, Le Kremlin-Bicêtre, Lille, Marseille
2009-12-10
Active, closed
Minimal SN Tumor Burden
NCT01942603Cutaneous Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Observational
296
Lille, Nice, Paris
2009-07
Recruiting
A Biological Atlas of Severe Obesity (Biological Tissue Collection)
NCT01129297Obesity, Glucose Intolerance, Diabetes
University Hospital, Lille
Observational
20,000
Lille
2006-06-13
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Bordeaux, Brest, Bron, Caen, La Tronche, Lille, Marseille, Nancy
2004-09-15
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Observational
4,050
Besançon, Clichy, Créteil, Lille, Lyon, Nancy, Paris, Poitiers
2003-01-01
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Bordeaux, Bron, Garches, Lille, Saint-Priest-en-Jarez, Strasbourg
2001-07-31
Rows per page Showing 1001–1282 of 1282
Previous 1 2 3
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 October 2026. https://priyalifescience.com/clinical-trials-france/city/lille?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,282 of those studies with a site in Lille.

How many clinical trials are recruiting in Lille?

711 of the 1,282 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 89 have not yet opened recruitment, 466 are active but closed to new participants, and 16 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.